» Articles » PMID: 31530679

Discovery of the Lyme Disease Agent

Overview
Journal mBio
Specialty Microbiology
Date 2019 Sep 19
PMID 31530679
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A detailed first-hand account of the events leading up to the discovery of the Lyme disease agent has been lacking. Nearly 40 years have elapsed since the discovery of the organism that was named There are thousands of articles in the scientific and medical literature on this organism and the disease that it causes. In the interval since the organism's discovery, however, misconceptions have arisen regarding not only the disease but the discovery itself. Accordingly, with this paper, we aim to fill in the details of this episode in medical history with a joint introduction, first-person accounts by the two authors, a summary of contemporaneous events, and concluding comments. The history of the discovery of the Lyme disease agent has threads originating in different places in the United States. Studies on Long Island, NY, provided the epidemiological thread of studies on rickettsial diseases and babesiosis, linking the latter with the cutaneous manifestation of Lyme disease, now known as erythema migrans. The Long Island thread intersected Montana's Rocky Mountain Laboratories thread of studies on a relapsing fever and its cultivation and expertise in vector biology. This intersection made possible the discovery of the spirochete and its recovery from patients. This paper stresses that what may seem to have been an individual scientific discovery is actually the product of several threads coming together and is attributable to more people than appreciated.

Citing Articles

Public health significance of the white-tailed deer (Odocoileus virginianus) and its role in the eco-epidemiology of tick- and mosquito-borne diseases in North America.

Rochlin I, Kenney J, Little E, Molaei G Parasit Vectors. 2025; 18(1):43.

PMID: 39915849 PMC: 11803971. DOI: 10.1186/s13071-025-06674-6.


Lyme borreliosis in Brazil: a critical review on the Baggio-Yoshinari syndrome (Brazilian Lyme-like disease).

Labruna M, Faccini-Martinez A, Munoz-Leal S, Szabo M, Angerami R Clin Microbiol Rev. 2024; 37(4):e0009724.

PMID: 39494872 PMC: 11629638. DOI: 10.1128/cmr.00097-24.


Lyme Neuroborreliosis in the Context of Dementia Syndromes.

Bashchobanov D, Stamatova E, Andonova R, Dragusheva E, Gadzhovska V, Popov G Cureus. 2024; 16(8):e67057.

PMID: 39286695 PMC: 11403646. DOI: 10.7759/cureus.67057.


Hitchhiker's Guide to .

Bourgeois J, Hu L J Bacteriol. 2024; 206(9):e0011624.

PMID: 39140751 PMC: 11411949. DOI: 10.1128/jb.00116-24.


Lyme Arthritis: A 50-Year Journey.

Steere A J Infect Dis. 2024; 230(Supplement_1):S1-S10.

PMID: 39140724 PMC: 11322885. DOI: 10.1093/infdis/jiae126.


References
1.
BURGDORFER W . Discovery of the Lyme disease spirochete: a historical review. Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 263(1-2):7-10. DOI: 10.1016/s0176-6724(86)80094-3. View

2.
Steere A, Grodzicki R, Kornblatt A, Craft J, Barbour A, BURGDORFER W . The spirochetal etiology of Lyme disease. N Engl J Med. 1983; 308(13):733-40. DOI: 10.1056/NEJM198303313081301. View

3.
BURGDORFER W, Barbour A, Hayes S, Peter O, Aeschlimann A . Erythema chronicum migrans--a tickborne spirochetosis. Acta Trop. 1983; 40(1):79-83. View

4.
Barbour A, BURGDORFER W, GRUNWALDT E, Steere A . Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest. 1983; 72(2):504-15. PMC: 1129208. DOI: 10.1172/jci110998. View

5.
Mast W, Burrows Jr W . Erythema chronicum migrans in the United States. JAMA. 1976; 236(7):859-60. View